• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
PoliticsRFK Jr.

Analysts at Trump ally Howard Lutnick’s former firm call RFK Jr. ‘an anti-vax, conspiracy theorist with inadequate training’

Marco Quiroz-Gutierrez
By
Marco Quiroz-Gutierrez
Marco Quiroz-Gutierrez
Reporter
Marco Quiroz-Gutierrez
By
Marco Quiroz-Gutierrez
Marco Quiroz-Gutierrez
Reporter
April 2, 2025, 5:54 AM ET
Robert F. Kennedy Jr., US secretary of Health and Human Services (HHS).
Robert F. Kennedy Jr., US secretary of Health and Human Services (HHS).Samuel Corum—Sipa/Bloomberg via Getty Images
  • Analysts at Wall Street firm Cantor Fitzgerald, formerly led by Commerce Secretary Howard Lutnick, called on the Trump administration to “reevaluate” RFK Jr.’s role as secretary of the Department of Health and Human Services. The HHS secretary last week reportedly forced the FDA’s top vaccine official to resign. 

Analysts at the Wall Street firm formerly led by Commerce Secretary Howard Lutnick want Health and Human Services Secretary Robert F. Kennedy Jr. Dismissed.

Recommended Video

In a note, Cantor Fitzgerald analysts Josh Schimmer and Eric Schmidt called for the Trump administration to “reevaluate” RFK Jr.’s role, following the resignation of the Food and Drug Administration’s top vaccine official.

The official, Peter Marks, was reportedly forced to resign by Kennedy last week with the approval of newly confirmed FDA commissioner Marty Makary, Politico reported. The FDA falls under the umbrella of HHS.

The Cantor Fitzgerald analysts criticized Kennedy’s leadership and his plans to remake HHS. Last week, Kennedy said HHS will lay off around 10,000 people, the first round of which began on Tuesday, CBS Newsreported.

“We call on the administration to re-evaluate RFK Jr’s role at HHS. Pushing out one of the most trusted leaders of the FDA to promote an anti-science agenda is a step too far for us,” the analysts wrote. “HHS cannot be led by an anti-vax, conspiracy theorist with inadequate training.”

The analysts added that RFK Jr. Was “undermining the trusted leadership of health care in this country.”

A spokesperson for Cantor Fitzgerald emphasized the independence of its analysts in a statement to Coins2Day.

“The views expressed in our Equity Research reports are solely those of the analyst(s). As always, we pride ourselves on the independence of the analysts within our Research division,” the spokesperson said.

The White House and HHS did not immediately respond to Coins2Day’s request for comment.

Former FDA commissioner Robert Califf also commented on Marks’ dismissal.

“I had the chance to work closely with him, and while many people disagreed with one or another decision he made, I can assert that his interest was always with the combination of public health and the special needs of patients in this rapidly evolving world of technology.”

Share prices of some of the biggest vaccine makers, including Merck, Moderna, and Pfizer fell. Moderna led the losses, closing down more than 4% Tuesday. Both Pfizer and Merck closed down about 3%.

In his resignation letter, Marks took a final shot at Kennedy’s leadership at HHS.

“I was willing to work to address the Secretary’s concerns regarding vaccine safety and transparency,” Marks wrote. “However, it has become clear that truth and transparency are not desired by the Secretary, but rather he wishes subservient confirmation of his misinformation and lies.”

Coins2Day Brainstorm AI returns to San Francisco Dec. 8–9 to convene the smartest people we know—technologists, entrepreneurs, Coins2Day Global 500 executives, investors, policymakers, and the brilliant minds in between—to explore and interrogate the most pressing questions about AI at another pivotal moment. Register here.
About the Author
Marco Quiroz-Gutierrez
By Marco Quiroz-GutierrezReporter
LinkedIn iconTwitter icon

Role: Reporter
Marco Quiroz-Gutierrez is a reporter for Coins2Day covering general business news.

See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.